Convergence Investment Partners, LLC Alkermes Plc. Transaction History

Convergence Investment Partners, LLC

  • $365 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$26.4 - $32.56 $529,795 - $653,414
20,068 New
20,068 $543,000
Q4 2021

Jan 25, 2022
SELL
$21.47 - $32.08 $178,845 - $267,226
-8,330 Closed
0 $0
Q3 2021

Oct 25, 2021
SELL
$23.37 - $32.13 $69,852 - $96,036
-2,989 Reduced 26.41%
8,330 $257,000
Q2 2021

Jul 19, 2021
BUY
$18.78 - $25.15 $212,570 - $284,672
11,319 New
11,319 $278,000

Others Institutions Holding ALKS

# of Institutions
363
Shares Held
182M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.8B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email